Navigation Links
In a technical tour de force, Salk scientists take a global view of the epigenome

A collaboration between researchers at the Salk Institute for Biological Studies and the University of California at Los Angeles captured the genome-wide DNA methylation pattern of the plant Arabidopsis thaliana - the "laboratory rat" of the plant world - in one big sweep.

"In a single experiment we recapitulated 20 years worth of anecdotal findings and then some," says senior author Joseph Ecker, Ph.D., a professor in the Salk Institute's Plant Biology Laboratory. "Previously, only a hand full of plant genes were known to be regulated by methylation. In addition to those, we found hundreds of others."

These technological innovations, pioneered by Ecker's team and that of Steve Jacobsen, Ph.D., a Howard Hughes Medical Institute investigator at UCLA, should have broad impact on the analysis of the human genome, stem cell biology and therapeutic cloning. Their findings will appear in a forthcoming issue of Cell.

Our view of heredity has largely been written in the language of DNA, but recent discoveries in a field known as epigenetics - the study of heritable changes in gene function that occur without changing the letters of the DNA alphabet - show that how a cell "reads" those letters is critical.

Methylation is chemical modification of one letter C (cytosine) of the four letters (A, G, C, and T) reiterated in our DNA. Adding a bulky methyl group to a C often blocks interaction with proteins required to activate gene expression, effectively silencing the methylated gene.

Ecker and Jacobsen were funded by the National Human Genome Research Institute (NHGRI), which launched a public consortium known as ENCODE, for the Encyclopedia Of DNA Elements. Now that the human genome has been sequenced, ENCODE aims to develop technology to decipher what 30 million (1%) of those letters "spell" by identifying not only what genes they encode, but how epigenetic modifications switch genes off and on. Once that's achieved, the effort w ill be scaled up to learn more about the dynamics of the whole human genome.

The approach developed by Ecker and collaborators may allow researchers to do just that. "We fit the whole Arabidopsis genome - about 120 million bases - on a single high density microarray," says Ecker. "To look at the entire human genome you would just need six more chips."

Each microarray or DNA chip is dotted with 6 million short DNA fragments that span the Arabidopsis genome like floor tiles. The researchers first isolated all methylated DNA from plant cells and located where those fragments fell on the array. Then they determined which genes were active and which ones weren't in order to compare gene activation with the methylation pattern.

The investigators saw significant changes when they compared activity of genes in normal plants with gene activity in plant mutants unable to methylate DNA. "It was pretty dramatic. There are hundreds of genes that you never see expressed except in methylation mutants," says Ecker.

Almost a third of Arabidopsis' ~ 26,000 genes were methylated in some manner, and where they were methylated determined the effect. As in mammals, methylation in regulatory regions next to genes generally silenced genes. However, methylation across the body of a gene appeared to correlate with higher expression.

Different cell types show different methylation patterns. DNA methylation in stem cells differs from that in a mature skin or nerve cell. Part of the makeover mature cells must undergo for therapeutic cloning purposes will likely involve remodeling methylation patterns to resemble those of stem cells. And disease states, ranging from retardation to cancer, are marked by aberrant methylation: some carcinogens cause cancer by methylating the "wrong" genes, leading to uncontrolled growth.

Once a cell's DNA methylation pattern - be it normal or pathological - is established, methylated sites are faithfully inher ited by daughter cells. The ability to take a high-resolution snapshot of what genes are methylated and which ones aren't during different developmental or disease states might show how cells self-renew or growth control genes become de-regulated.

The investigators also found that methylation silences transposons, so-called "jumping genes," which can wreak genomic havoc by hopping about the chromosomes. In the words of Ecker, undermethylated transposons "just go wild," suggesting that mother nature keeps transposons in time-out by covering them with methyl groups.
'"/>

Source:Salk Institute


Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... States multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® ... identifying clinically significant acute bacterial and viral respiratory tract infections by testing ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: